Hollow-fiber-based supported liquid membrane was modified utilizing nanostructures such as graphite, graphene oxide or nitrogen-doped graphene oxide, for electro-membrane extraction (EME) of imatinib and sunitinib from biological fluids. By applying these conductive nanostructures, a low-voltage EME device (6.0 V) was fabricated. A response surface methodology through central composite design was used to evaluate and optimize effects of various essential factors that influence on normalized recovery. Optimal extraction conditions were set as, 1-octanol with 0.01 % (w/v) graphene oxide functioning as the supported liquid membrane, an extraction time of 17.0 min, pH of the acceptor and the donor phase of 2.8 and 7.9, respectively. The method was successfully applied to quantify imatinib and sunitinib in biological fluids.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4155/bio-2021-0138 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of Angiogenesis-Related Gene Signatures and Prediction of Potential Therapeutic Targets in Ulcerative Colitis Using Integrated Bioinformatics.
J Inflamm Res
December 2024
Department of General Surgery, Taizhou First People's Hospital, Taizhou, Zhejiang, People's Republic of China.
Objective: This study aims to clarify angiogenesis mechanisms in ulcerative colitis and identify potential therapeutic targets.
Methods: The Gene Expression Omnibus (GEO) database was used to obtain expression profiles and clinical data for UC and healthy colon tissues. Angiogenesis-related gene sets were acquired from GeneCards.
Identification of D842V mutation in gastrointestinal stromal tumors based on CT radiomics: a multi-center study.
Cancer Imaging
December 2024
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Pujian Road 160, Pudong District, 200127, Shanghai, China.
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Recent advent of tyrosine kinase inhibitors (TKIs) has significantly improved the prognosis of GIST patients. However, responses to TKI therapy can vary depending on the specific gene mutation.
View Article and Find Full Text PDF[Rethinking several issues related to surgical treatment for advanced GIST in the era of targeted therapy].
Zhonghua Wei Chang Wai Ke Za Zhi
November 2024
Department of Gastrointestinal Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai200127, China.
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the gastrointestinal tract, and tyrosine kinase inhibitors (TKIs) have achieved great success in the treatment of GISTs. The role and value of surgery in advanced GISTs are still controversial. This article aims to review the progress related to surgery for advanced GIST in the context of targeted therapy, particularly exploring the issues related to the combination of surgery and targeted therapy.
View Article and Find Full Text PDFTwo Decades of Gastrointestinal Stromal Tumor Management With First-Line Treatment: A Case Report.
Cureus
October 2024
Paliative Care, Unidade Local de Saúde de Braga, Braga, PRT.
Gastrointestinal stromal tumors (GISTs) are rare malignant tumors that arise from the connective tissues of the gastrointestinal tract. Reports about GISTs treated with imatinib for over five years are exceedingly rare. In this case report, we present a patient with GIST who remained alive for two decades after undergoing imatinib treatment.
View Article and Find Full Text PDFOverall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability.
J Cancer Res Clin Oncol
November 2024
Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany.
Purpose: The prognosis of patients with metastatic GIST and imatinib-sensitive primary mutations has significantly improved. However, limited data are available to inform patients about outcomes across different lines of treatment. This retrospective analysis aims to evaluate patient outcomes at a large German GIST referral center over the past 15 years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!